In the last trading session, 1.17 million uniQure N.V (NASDAQ:QURE) shares changed hands as the company’s beta touched 0.85. With the company’s per share price at $6.41 changed hands at -$0.72 or -10.10% during last session, the market valuation stood at $312.44M. QURE’s last price was a discount, traded about -77.07% off its 52-week high of $11.35. The share price had its 52-week low at $3.73, which suggests the last value was 41.81% up since then. When we look at uniQure N.V’s average trading volume, we note the 10-day average is 0.82 million shares, with the 3-month average coming to 722.62K.
Analysts gave the uniQure N.V (QURE) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.69. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended QURE as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. uniQure N.V’s EPS for the current quarter is expected to be -0.53.
uniQure N.V (NASDAQ:QURE) trade information
Instantly QURE was in red as seen at the end of in last trading. With action 7.01%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -5.32%, with the 5-day performance at 7.01% in the green. However, in the 30-day time frame, uniQure N.V (NASDAQ:QURE) is 9.39% up. Looking at the short shares, we see there were 3.17 million shares sold at short interest cover period of 4.2 days.
The consensus price target for the stock as assigned by Wall Street analysts is 57.5, meaning bulls need an upside of 88.85% from its current market value. According to analyst projections, QURE’s forecast low is 34 with 62 as the target high. To hit the forecast high, the stock’s price needs a -867.24% plunge from its current level, while the stock would need to soar -430.42% for it to hit the projected low.
uniQure N.V (QURE) estimates and forecasts
Data shows that the uniQure N.V share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 18.27% over the past 6 months, a 42.19% in annual growth rate that is considerably higher than the industry average of 17.60%. Year-over-year growth is forecast to reach 145.16% up from the last financial year.
Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 18.39M. 8 analysts are of the opinion that uniQure N.V’s revenue for the current quarter will be 6.41M. The company’s revenue for the corresponding quarters a year ago was 6.16M and 7.87M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 198.27%. The estimates for the next quarter sales put growth at -18.51%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -22.59%. The 2024 estimates are for uniQure N.V earnings to increase by 36.74%.
QURE Dividends
uniQure N.V is expected to release its next quarterly earnings report in January.
uniQure N.V (NASDAQ:QURE)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 9.23% of uniQure N.V shares while 81.79% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 90.10%. There are 81.79% institutions holding the uniQure N.V stock share, with VESTAL POINT CAPITAL, LP the top institutional holder. As of 2024-06-30, the company held 9.8172% of the shares, roughly 4.75 million QURE shares worth $21.28 million.
NANTAHALA CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 5.4779% or 2.65 million shares worth $11.87 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were abrdn Healthcare Investors and Vanguard Extended Market Index Fund . With 1.04 shares estimated at $6.66 million under it, the former controlled 2.13% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.47% of the shares, roughly 717.32 shares worth around $4.6 million.
